David Langan is a Senior Scientist at Deka Biosciences, where they lead R&D efforts for biologics and develop advanced methodologies for oncology treatments. Previously, Langan worked as a Scientist at NexImmune, Inc., where they enhanced screening capabilities for T cell therapies and contributed to high-impact publications. They began their research career as a PostBacc Research Fellow at USAMRIID, gaining recognition for their work in drug development and antibody production. Langan holds a PhD in Microbiology and Immunology from the University of Maryland, Baltimore, and a BA in Biochemistry from Hood College.
This person is not in any teams
This person is not in any offices